Related references
Note: Only part of the references are listed.Cancer-targeted photoimmunotherapy induces antitumor immunity and can be augmented by anti-PD-1 therapy for durable anticancer responses in an immunologically active murine tumor model
Michelle A. Hsu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2023)
Click Chemistry-Generated Auristatin F-Linker-Benzylguanine for a SNAP-Tag-Based Recombinant Antibody-Drug Conjugate Demonstrating Selective Cytotoxicity toward EGFR-Overexpressing Tumor Cells
Allan M. Huysamen et al.
ACS OMEGA (2023)
Antibody-drug conjugates in lung cancer: dawn of a new era?
Niamh Coleman et al.
NPJ PRECISION ONCOLOGY (2023)
Ladiratuzumab vedotin for metastatic triple negative cancer: preliminary results, key challenges, and clinical potential
Alessandro Rizzo et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2022)
Different methods of detaching adherent cells and their effects on the cell surface expression of Fas receptor and Fas ligand
Ting-Yu Lai et al.
SCIENTIFIC REPORTS (2022)
Co-Expression and Combined Prognostic Value of CSPG4 and PDL1 in TP53-Aberrant Triple-Negative Breast Cancer
Zhe-Yu Hu et al.
FRONTIERS IN ONCOLOGY (2022)
Single-Chain Fragment Variable: Recent Progress in Cancer Diagnosis and Therapy
Paola Munoz-Lopez et al.
CANCERS (2022)
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
Larissa A. Korde et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Expression of chondroitin sulfate proteoglycan 4 (CSPG4) in melanoma cells is downregulated upon inhibition of BRAF
Karolina Uranowska et al.
ONCOLOGY REPORTS (2021)
Multiplexed immunofluorescence identifies high stromal CD68+PD-L1+ macrophages as a predictor of improved survival in triple negative breast cancer
James Wang et al.
SCIENTIFIC REPORTS (2021)
Cancer statistics for the year 2020: An overview
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
A comprehensive comparison between camelid nanobodies and single chain variable fragments
Yasaman Asaadi et al.
BIOMARKER RESEARCH (2021)
Microtubule and tubulin binding and regulation of microtubule dynamics by the antibody drug conjugate (ADC) payload, monomethyl auristatin E (MMAE): Mechanistic insights into MMAE ADC peripheral neuropathy
Rebecca L. Best et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2021)
FDA Approval Summary: Accelerated Approval of Sacituzumab Govitecan-hziy for Third-line Treatment of Metastatic Triple-negative Breast Cancer
Sakar Wahby et al.
CLINICAL CANCER RESEARCH (2021)
Impact of cell harvesting methods on detection of cell surface proteins and apoptotic markers
A. Nowak-Terpilowska et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2021)
Multiplex immunofluorescence to measure dynamic changes in tumor-infiltrating lymphocytes and PD-L1 in early-stage breast cancer
Katherine Sanchez et al.
BREAST CANCER RESEARCH (2021)
In Vivo Cell Fate Tracing Provides No Evidence for Mesenchymal to Epithelial Transition in Adult Fallopian Tube and Uterus
Arnab Ghosh et al.
CELL REPORTS (2020)
A Novel Antibody-Drug Conjugate (ADC) Delivering a DNA Mono-Alkylating Payload to Chondroitin Sulfate Proteoglycan (CSPG4)-Expressing Melanoma
Ricarda M. Hoffmann et al.
CANCERS (2020)
Advances in Antibody-Drug Conjugate Design: Current Clinical Landscape and Future Innovations
Laurence Gauzy-Lazo et al.
SLAS DISCOVERY (2020)
Molecular subtypes and precision treatment of triple-negative breast cancer
Shen Zhao et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Advances in epidermal growth factor receptor specific immunotherapy: lessons to be learned from armed antibodies
Fleury Augustin Nsole Biteghe et al.
Oncotarget (2020)
Antibody-Based Immunotherapy: Alternative Approaches for the Treatment of Metastatic Melanoma
Fleury Augustin Nsole Biteghe et al.
BIOMEDICINES (2020)
The Analysis of Key Factors Related to ADCs Structural Design
Haichao Tang et al.
FRONTIERS IN PHARMACOLOGY (2019)
One-step site-specific antibody fragment auto-conjugation using SNAP-tag technology
Ahmad Fawzi Hussain et al.
NATURE PROTOCOLS (2019)
Antibody-drug conjugates: Promising and efficient tools for targeted cancer therapy
Hadi Nasiri et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Fate of Antibody-Drug Conjugates in Cancer Cells
Cecile Chalouni et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Enhanced targeting of triple-negative breast carcinoma and malignant melanoma by photochemical internalization of CSPG4-targeting immunotoxins
M. S. Eng et al.
PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES (2018)
Treating Tissue Factor-Positive Cancers with Antibody-Drug Conjugates That Do Not Affect Blood Clotting
Jan-Willem Theunissen et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Site-Specific Conjugation of Auristatins onto Engineered scFv Using Second Generation Maleimide to Target HER2-positive Breast Cancer in Vitro
Nicolas Aubrey et al.
BIOCONJUGATE CHEMISTRY (2018)
Quantitative Flow Cytometry: Concerns and Recommendations in Clinic and Research
Olga Mizrahi et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2018)
Elements of cancer immunity and the cancer-immune set point
Daniel S. Chen et al.
NATURE (2017)
Comparison of a mouse and a novel human scFv-SNAP-auristatin F drug conjugate with potent activity against EGFR-overexpressing human solid tumor cells
Mira Woitok et al.
ONCOTARGETS AND THERAPY (2017)
An anti-HER2 antibody conjugated with monomethyl auristatin E is highly effective in HER2-positive human gastric cancer
Hongwen Li et al.
CANCER BIOLOGY & THERAPY (2016)
The efficient elimination of solid tumor cells by EGFR-specific and HER2-specific scFv-SNAP fusion proteins conjugated to benzylguanine-modified auristatin F
Mira Woitok et al.
CANCER LETTERS (2016)
Preclinical Efficacy of the Auristatin-Based Antibody-Drug Conjugate BAY 1187982 for the Treatment of FGFR2-Positive Solid Tumors
Anette Sommer et al.
CANCER RESEARCH (2016)
Intracellular Released Payload Influences Potency and Bystander-Killing Effects of Antibody-Drug Conjugates in Preclinical Models
Fu Li et al.
CANCER RESEARCH (2016)
A novel approach for targeted elimination of CSPG4-positive triple-negative breast cancer cells using a MAP tau-based fusion protein
Manal Amoury et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
A specific photoimmunotheranostics agent to detect and eliminate skin cancer cells expressing EGFR
Verena von Felbert et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)
Mechanisms of Resistance to Antibody-Drug Conjugates
Frank Loganzo et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Photoimmunotheranostic agents for triple-negative breast cancer diagnosis and therapy that can be activated on demand
Manal Amoury et al.
ONCOTARGET (2016)
Phototheranostics of CD44-positive cell populations in triple negative breast cancer
Jiefu Jin et al.
SCIENTIFIC REPORTS (2016)
Antibody Drug Conjugates: Design and Selection of Linker, Payload and Conjugation Chemistry
Jessica R. McCombs et al.
AAPS JOURNAL (2015)
Strategies and Advancement in Antibody-Drug Conjugate Optimization for Targeted Cancer Therapeutics
Eunhee G. Kim et al.
BIOMOLECULES & THERAPEUTICS (2015)
Compensation in multicolor flow cytometry
Gabor Szaloki et al.
CYTOMETRY PART A (2015)
Antibody-targeted drugs and drug resistance-Challenges and solutions
LeeRon Shefet-Carasso et al.
DRUG RESISTANCE UPDATES (2015)
Antitumor effect of antitissue factor antibody-MMAE conjugate in human pancreatic tumor xenografts
Yoshikatsu Koga et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Phage display-based generation of novel internalizing antibody fragments for immunotoxin-based treatment of acute myeloid leukemia
Jenny Fitting et al.
MABS (2015)
Sortase Enzyme-Mediated Generation of Site-Specifically Conjugated Antibody Drug Conjugates with High In Vitro and In Vivo Potency
Roger R. Beerli et al.
PLOS ONE (2015)
Auristatin Antibody Drug Conjugate Physical Instability and the Role of Drug Payload
Yilma T. Adem et al.
BIOCONJUGATE CHEMISTRY (2014)
Antibody-drug conjugates-A new wave of cancer drugs
Herve Bouchard et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Mammographic and clinicopathological features of triple-negative breast cancer
B. Gao et al.
BRITISH JOURNAL OF RADIOLOGY (2014)
Site-Specific Trastuzumab Maytansinoid Antibody-Drug Conjugates with Improved Therapeutic Activity through Linker and Antibody Engineering
Thomas H. Pillow et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Biological subtypes of breast cancer: Prognostic and therapeutic implications
Ozlem Yersal et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2014)
Investigation into Temperature-Induced Aggregation of an Antibody Drug Conjugate
Nia S. Beckley et al.
BIOCONJUGATE CHEMISTRY (2013)
Targeted Delivery of Dendritic Polyglycerol-Doxorubicin Conjugates by scFv-SNAP Fusion Protein Suppresses EGFR+ Cancer Cell Growth
Ahmad Fawzi Hussain et al.
BIOMACROMOLECULES (2013)
DCDT2980S, an Anti-CD22-Monomethyl Auristatin E Antibody-Drug Conjugate, Is a Potential Treatment for Non-Hodgkin Lymphoma
Dongwei Li et al.
MOLECULAR CANCER THERAPEUTICS (2013)
The PI3K/AKT Signaling Pathway Controls the Quiescence of the Low-Rhodamine123-Retention Cell Compartment Enriched for Melanoma Stem Cell Activity
Yasmine Touil et al.
STEM CELLS (2013)
Aptamer-Guided Silver-Gold Bimetallic Nanostructures with Highly Active Surface-Enhanced Raman Scattering for Specific Detection and Near-Infrared Photothermal Therapy of Human Breast Cancer Cells
Ping Wu et al.
ANALYTICAL CHEMISTRY (2012)
Pathological and molecular diagnosis of triple-negative breast cancer: a clinical perspective
F. Penault-Llorca et al.
ANNALS OF ONCOLOGY (2012)
Targeted drug delivery for cancer therapy: the other side of antibodies
Michael A. Firer et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2012)
Overcoming Multidrug Resistance via Photodestruction of ABCG2-Rich Extracellular Vesicles Sequestering Photosensitive Chemotherapeutics
Vicky Goler-Baron et al.
PLOS ONE (2012)
Versatile inhibitory effects of the flavonoid-derived PI3K/Akt inhibitor, LY294002, on ATP-binding cassette transporters that characterize stem cells
Yasuo Imai et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2012)
SNAP-Tag Technology Mediates Site Specific Conjugation of Antibody Fragments with a Photosensitizer and Improves Target Specific Phototoxicity in Tumor Cells
Ahmad Fawzi Hussain et al.
BIOCONJUGATE CHEMISTRY (2011)
Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells
Craig A. Cooney et al.
BREAST CANCER RESEARCH (2011)
CSPG4 in Cancer: Multiple Roles
X. Wang et al.
CURRENT MOLECULAR MEDICINE (2010)
Rapid optical imaging of EGF receptor expression with a single-chain antibody SNAP-tag fusion protein
Florian Kampmeier et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
CSPG4 Protein as a New Target for the Antibody-Based Immunotherapy of Triple-Negative Breast Cancer
Xinhui Wang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Anti-CD22-MCC-DM1: an antibody-drug conjugate with a stable linker for the treatment of non-Hodgkin's lymphoma
A. G. Polson et al.
LEUKEMIA (2010)
Melanoma Proteoglycan Modifies Gene Expression to Stimulate Tumor Cell Motility, Growth, and Epithelial-to-Mesenchymal Transition
Jianbo Yang et al.
CANCER RESEARCH (2009)
Basics of standardization and calibration in cytometry - a review
Anja Mittag et al.
JOURNAL OF BIOPHOTONICS (2009)
Modern Breast Cancer Detection: A Technological Review
Adam B. Nover et al.
INTERNATIONAL JOURNAL OF BIOMEDICAL IMAGING (2009)
Guanidinium-grafted polyethylenimine: An efficient transfecting agent for mammalian cells
Surendra Nimesh et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2008)
Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
Jagath R. Junutula et al.
NATURE BIOTECHNOLOGY (2008)
A single chain immunotoxin, targeting the melanoma-associated chondroitin sulfate proteoglycan, is a potent inducer of apoptosis in cultured human melanoma cells
Michael Schwenkert et al.
MELANOMA RESEARCH (2008)
Estrogen receptor-negative invasive breast cancer: Imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression
Yingbing Wang et al.
RADIOLOGY (2008)
Paul Ehrlich's magic bullet concept: 100 years of progress
Klaus Strebhardt et al.
NATURE REVIEWS CANCER (2008)
Potent cytotoxicity of an auristatin-containing antibody-drug conjugate targeting melanoma cells expressing melanotransferrin/p97
Leia M. Smith et al.
MOLECULAR CANCER THERAPEUTICS (2006)
The molecular portraits of breast tumors are conserved across microarray platforms
Zhiyuan Hu et al.
BMC GENOMICS (2006)
Engineered antibody fragments and the rise of single domains
P Holliger et al.
NATURE BIOTECHNOLOGY (2005)
Labeling of fusion proteins of O6-alkylguanine-DNA alkyltransferase with small molecules in vivo and in vitro
A Keppler et al.
METHODS (2004)
Melanoma chondroitin sulfate proteoglycan enhances FAK and ERK activation by distinct mechanisms
JB Yang et al.
JOURNAL OF CELL BIOLOGY (2004)
Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate
KJ Hamblett et al.
CLINICAL CANCER RESEARCH (2004)
Effect of pegylation on pharmaceuticals
JM Harris et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
